Organization · Venture Capital

Cape Fear BioCapital

Cape Fear BioCapital is an early-stage venture capital firm based in Durham, North Carolina, focused on investing in therapeutics companies emerging from the local research ecosystem. The firm targets pre-seed to seed-stage investments, leveraging regional academic resources to foster innovation in life sciences.

Venture CapitalFunder

Overview

What Cape Fear BioCapital does

What Cape Fear BioCapital is

Cape Fear BioCapital is an early-stage venture capital firm based in Durham, North Carolina, focused on investing in therapeutics companies emerging from the local research ecosystem. The firm targets pre-seed to seed-stage investments, leveraging regional academic resources to foster innovation in life sciences.

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Venture Capital
Founded
Founded in 2024
Approximate age
About 2 years
Structured capabilities
Funder
Last reviewed
May 3, 2026

Official channels

Find Cape Fear BioCapital elsewhere

Open the official website or a supported primary organization account.

Capability profile

Cape Fear BioCapital as a funder

Investment thesis

Cape Fear BioCapital invests where differentiated biology can become seed-ready therapeutics companies, focusing on pre-seed to seed stages, particularly those with clear paths to clinical development.

Focus narrative

Cape Fear BioCapital focuses on investing in early-stage therapeutics companies, particularly those rooted in North Carolina. The firm targets pre-seed to seed-stage investments in companies with validated scientific foundations and clear paths to clinical development. By emphasizing platform companies with multi-indication potential and single-asset programs, Cape Fear BioCapital aims to accelerate the clinical progress of its portfolio companies, especially those nearing Investigational New Drug (IND) filing.

Value beyond capital

Cape Fear BioCapital adds value to its portfolio companies by providing hands-on company building, operational support, and access to strategic partners. The firm focuses on helping founders secure intellectual property, complete proof-of-concept work, and attract follow-on investments, thereby accelerating the path from academic research to clinical application.

Availability

Currently deploying
Yes

Portfolio and track record

Recorded portfolio count
6

Portfolio context

Thoracic Innovations: A medical device company developing novel surgical tools for cardiothoracic surgery. (Location: Durham, NC) Ten63 Therapeutics: An AI-enabled drug discovery company leveraging its proprietary BEYOND platform to design small molecules for oncology. (Stage: Series A, Location: Durham, NC) Incyclix Bio: A clinical-stage oncology company advancing a selective CDK2 inhibitor for specific cancer types. (Stage: Series B, Location: Durham, NC) iOrganBio: A cell manufacturing platform company utilizing AI-driven predictions for the production of human cells and organoids. (Stage: Pre-Seed, Location: Durham, NC) EnFuego Therapeutics: An early-stage oncology company developing a breakthrough siRNA platform targeting difficult cancer pathways. (Stage: Pre-Seed, Location: Chapel Hill, NC) Eldec Pharmaceuticals: A peptide therapeutics company developing a modulator for chronic respiratory disease. (Stage: Pre-Seed, Location: Chapel Hill, NC)

Common questions

What to know about Cape Fear BioCapital

Upseed classifies Cape Fear BioCapital under the Venture Capital organization type. Its current public profile includes funder capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

May 3, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.